TRIB (trinitybiotech.com) Return on Sales by Gross Profit

Corporate emblem and logo of Trinity Biotech plc (TRIB)

Analyzing the gross profit to revenue ratio on GURU.Markets, we find that 33.00 is the current value of the metric, confirming the profitability of global supplies of diabetes diagnostic equipment for Trinity Biotech plc (TRIB). The business foundation is supported by updated management focused on debt repayment and stringent FDA/CE certifications, which create an insurmountable barrier for competitors in the hospital sector.

trinitybiotech.com (TRIB) - Return on Gross Profit from 07/04/2022 to 11/19/2026

Financial and market metric breakdowns for Trinity Biotech PLC (TRIB)

Fundamental valuation:TRIB - trinitybiotech.com
Manufactured products of Trinity Biotech

Trinity Biotech plc (TRIB) procures test components from third-party suppliers, making the control of assembly costs a critical efficiency factor. This metric measures the profit share after deducting direct production costs, allowing investors to distinguish temporary reagent price spikes from a systemic decline in profitability by analyzing the current gross margin to determine the asset's fair value.